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The 2007 bicentennial of the enactment
of the bill to abolish the transatlantic slave
trade in the British Empire has focused
new attention on the historical legacy of
slavery and its human and social con-
sequences. Beyond the societal impact of
slavery, which continues to the present
day, the transportation of millions of
persons from sub-Saharan Africa to the
New World also resulted in the importa-
tion of a number of parasitic diseases to
the Americas. Lymphatic filariasis (LF),
schistosomiasis, and onchocerciasis were
most likely imported to the Americas via
the slave trade; the presence of competent
vectors (such as mosquitoes, black flies,
and snails) allowed transmission and
dispersal of the parasites [1–4]. Although
parasitologists first speculated more than
a century ago that the slave trade was
responsible for introduction of these dis-
eases to the New World [3], only recently
has convincing evidence supporting this
hypothesis been generated. Molecular
evaluation of Schistosoma mansoni and Onch-
ocerca volvulus has demonstrated very limit-
ed heterogeneity among New World
strains, which share a strong affinity with
West African strains of these parasites
[5,6]. Poverty and poor living conditions
continue to put people at risk of LF,
schistosomiasis, and onchocerciasis. On
the 200th anniversary of the abolition of
the slave trade, a fitting commemoration
would be a commitment to the regional
eradication of these three diseases that
remain as a historical legacy of slavery.
Lymphatic filariasis is a mosquito-trans-
mitted infection that is associated with the
development of debilitating lymphedema,
elephantiasis, and hydrocele. The princi-
pal mosquito vector in the Americas, Culex
quinquefasciatus, breeds in polluted water
and is adapted to urban environments. LF
once was widely distributed throughout
the region, particularly in areas where the
local geography was amenable to planta-
tion-based agriculture and large numbers
of slaves were imported. Economic de-
velopment in the United States and in the
Caribbean led to the spontaneous disap-
pearance of LF in some areas and sub-
stantial declines in the prevalence of
infection in others [7]. Ongoing trans-
mission in the Western Hemisphere, now
limited to four countries (Brazil, the
Dominican Republic, Haiti, and Guyana),
is concentrated in impoverished settings
and appears to be a growing problem in
urban slums. LF elimination programs
based on the mass distribution of anti-
filarial drugs have been developed in all
four countries and have resulted in
declines in the prevalence of filarial in-
fection ([8] and unpublished data). How-
ever, all four programs are resource
challenged and none have achieved full
coverage of at-risk populations.
Onchocerciasis is well recognized as
a cause of blindness and skin disease due
to the pathology elicited by death of
microfilariae in the tissues. Transmission
of onchocerciasis in the Americas is now
limited to 13 foci in six countries (Mexico,
Guatemala, Columbia, Brazil, Venezuela
and Ecuador) [9]. The Onchocerciasis
Elimination Program in the Americas is
coordinating twice-yearly mass treatment
with ivermectin in these foci. Impressive
strides have been made in reducing the
prevalence of onchocercal disease, and in
some foci interruption of transmission has
been achieved, leading to the decision to
halt mass treatment in one focus in
Guatemala. End-game strategies for com-
pleting the interruption of transmission in
the remaining active foci must now be
validated [10].
2007 also marks the centenary of the
first description of Schistosoma mansoni, the
causative agent of schistosomiasis in
the Americas. Schistosomiasis was once
widespread throughout the Caribbean and
South America and was a major cause of
hepatic fibrosis and death. Through selec-
tive and mass treatment campaigns, snail
control efforts, and improved sanitation,
the prevalence of schistosomiasis in the
Americas has decreased and fatal infec-
tions are now uncommon. However, the
‘‘subtle morbidities’’ of anemia and altered
growth and cognitive development in
children caused by schistosomiasis are
increasingly recognized as public health
problems [11]. Millions of persons in
Brazil are still at risk of infection, but the
official status of schistosomiasis transmis-
sion in a number of other former slave
colonies with previously documented
transmission, such as Suriname and Saint
Lucia, is not known [12]. The biological
and epidemiological characteristics of
schistosomiasis make it much more chal-
lenging to eliminate than lymphatic filari-
asis or onchocerciasis. Because adult
worms can live within hosts for years and
the diagnostic tests to detect active in-
fection and confirm successful cure are
currently inadequate as public health
tools, it is possible that an elimination
strategy based exclusively on drug treat-
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ment will not be successful. On the other
hand, provision of safe water and sanitary
improvements in the remaining endemic
foci is a valid public health goal that will
yield important dividends beyond schisto-
somiasis control. Given the substantial
decline in infection prevalence that al-
ready has occurred in the region, de-
velopment of the tools and strategies that
will complete the task of elimination in this
hemisphere deserves serious consideration.
A new focus on neglected tropical
diseases (NTDs), including LF, onchocer-
ciasis, and schistosomiasis, by the World
Health Organization and the global health
community holds the promise of delivering
significant benefits to populations that
suffer from these diseases [13]. However,
little attention has been focused on the
Americas, in large part because of the
focal distribution of these infections and
the mistaken impression that the NTDs no
longer represent a public health burden in
the region. Recently, several authors have
drawn attention to the burden of NTDs in
the Americas, and have recommended
potential solutions [14]. Equally important
is the recognition that these diseases in the
Americas, in contrast to the situation in
Africa, can actually be eliminated with
proper efforts [15]. Although significant
progress has been made in reducing the
prevalence of LF, onchocerciasis, and
schistosomiasis in the Americas, these
diseases continue to represent a threat to
millions of persons, particularly in eco-
nomically marginalized communities.
Slavery and the slave trade have been
prohibited in all their forms by international
human rights declarations and treaties that
also protect the life, well being, personal
freedom, and the physical and mental
integrity of human beings [16]. In recent
years, the topic of reparations for slavery has
been a contentious political topic. One of the
major difficulties with this concept is that
neither the perpetrators nor direct victims of
the slave trade are available to make or
receive restitution. On the other hand, the
elimination of diseases that are a conse-
quence of this trade would represent
a tangible contribution to the health and
well being of people and communities who,
arguably, still suffer from the residual affects
of slavery. What is needed now is renewal of
political will and a dedication of new
financial and technical resources to a co-
ordinated elimination effort consistent with
international human rights treaties and
guidelines that recognize the ‘‘right to the
highest attainable standard of physical and
mental health,’’ which includes the pre-
vention, treatment, and control of epidemic,
endemic, occupational, and other diseases
[17,18]. Control and elimination of NTDs
from endemic areas is central to ensuring the
promotion and protection of human rights.
We recognize that LF, onchocerciasis,
and schistosomiasis are not the only
diseases to have been imported to the
Western Hemisphere through the slave
trade. They are, however, diseases that still
cause substantial morbidity 200 years after
the end of the slave trade and are
particularly attractive elimination targets.
In advocating for the elimination of NTDs
in the Western Hemisphere, we are not
ignoring the greater burden of NTDs in
sub-Saharan Africa. However, as noted by
several recent reports from the Interna-
tional Task Force for Disease Eradication,
eliminating these diseases in the Americas
is now feasible, whereas the situation in
Africa is not so promising [15,19]. Recent
advocacy efforts for NTDs have made
a strong case for the public health and
economic value of these interventions and
the dramatic health benefits that integrat-
ed NTD programs can provide [13].
These efforts have led to significant new
financial commitments by the Bill&Me-
linda Gates Foundation and the United
Kingdom and United States governments
and to new discussions with the Global
Fund to Fight AIDS, Tuberculosis and
Malaria about linking NTD programs to
those targeting HIV, malaria, and tuber-
culosis [20]. Efforts to eradicate LF,
onchocerciasis, and schistosomiasis in the
Americas will provide critical operational
experience with strategies to interrupt
transmission in residual foci and low-
prevalence settings. They will also be
instructive in the development of tools to
conduct surveillance following the cessation
of mass treatment. This experience will
benefit the African programs and galvanize
increased support for the elimination of
NTDs in Africa by demonstrating ap-
proaches that make this an achievable goal.
Nevertheless, the global experience with
guinea worm eradication portends that
these efforts will not be easy. But the effort
to eradicate slavery was not easy either.
Slave revolts and rebellions occurred
throughout the period of slavery with great
loss of life on both sides. William Wilber-
force worked for 20 years against great
opposition to achieve passage of the law
ending the British slave trade (trafficking) in
1807. And he worked another 26 years
until Parliament abolished slavery itself in
the British colonies. During those years, the
anti-slavery proponents carried medallions
similar to the ribbons and bracelets com-
monly worn today to signify support for
various causes or diseases. On these medal-
lions was printed ‘‘Am I not a man and
a brother?’’ (Figure 1). Elimination of LF,
onchocerciasis, and schistosomiasis in the
Americas is a worthy goal for public health
and for the enjoyment of physical and
mental health as a basic human right,
a learning tool for NTD control in more
challenging settings, and a continuation of
the efforts and struggles for justice of those
who suffered the inhumanity of slavery and
of those who worked to halt the slave trade
200 years ago. Now is the time to continue
this pioneering work to eliminate three of
the lasting legacies of slavery.
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